§15–601.

    (a)    In this subtitle the following words have the meanings indicated.

    (b)    “Board” means the State Board of Pharmacy.

    (c)    “Dispense” means to provide:

        (1)    A prescription drug or medical supply in accordance with a prescription; or

        (2)    An over–the–counter drug or medical supply.

    (d)    “Drop–off site” means a pharmacy, other health care facility, or other entity participating in a drug donation or repository program and designated by the Board that:

        (1)    Has voluntarily agreed to accept donated prescription drugs, over–the–counter drugs, or medical supplies;

        (2)    Is located within the State or in another state; and

        (3)    Does not have a final disciplinary order issued against it by a health occupations board.

    (e)    “Eligible patient” means an individual who, through self–attestation, is indigent, uninsured, underinsured, or enrolled in a public health benefits program.

    (f)    “Program” means the Prescription Drug Repository Program.

    (g)    “Repository” means a licensed pharmacy that:

        (1)    If the licensed pharmacy is located in the State, does not have a final disciplinary order issued against it by the Board of Pharmacy;

        (2)    Has voluntarily agreed to participate in the Program;

        (3)    Is located in the State or in another state; and

        (4)    Has been approved by the Board to:

            (i)    Accept donated prescription drugs, over–the–counter drugs, or medical supplies from a designated drop–off site;

            (ii)    Dispense the donated prescription drugs, over–the–counter drugs, or medical supplies to eligible patients; or

            (iii)    Dispose of prescription drugs, over–the–counter drugs, or medical supplies not accepted for dispensing to eligible patients.

    (h)    “Tamper–evident packaging” means a packaging system that:

        (1)    May involve an immediate–container and closure system, secondary–container or carton system, tertiary–container system, or other combination of systems intended to provide a visual indication of package integrity;

        (2)    May contain unit–dose or multi–dose contents; and

        (3)    Has one or more indicators or barriers to entry that:

            (i)    If breached or missing, can reasonably be expected to provide visible evidence to consumers that tampering has occurred; and

            (ii)    If handled in a reasonable manner during manufacture, distribution, or retail display, is designed to remain intact.